CVS Health price target raised by $5 at Evercore ISI, here’s why

Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on CVS Health to $85 from $80 and keeps an Outperform rating on the shares. Following the company’s investor day, Evercore says the firm liked the company’s new approach to guidance, which “conservatively” points to 6% EPS growth with the opportunity for upside in a variety of areas.